Fadi M. Alkhateeb, Patricia Baidoo, Marija Mikulskis Cavana, Danielle Gill, Amanda Howell, Babak Mehraeen and Carrie Weidner
Pharmaceutical sales representatives (PSRs) have been shown to influence the prescribing patterns of physicians. Some of the blame has been shifted from physicians to PSRs due to…
Abstract
Purpose
Pharmaceutical sales representatives (PSRs) have been shown to influence the prescribing patterns of physicians. Some of the blame has been shifted from physicians to PSRs due to perceived inadequacies in PSRs' education and certification. The purpose of this paper is to review the literature regarding the current certification requirements for PSRs, motivation for nationally standardized certification and the controversy surrounding pharmaceutical detailing impact on physicians' prescribing behavior.
Design/methodology/approach
Articles related to certification for PSRs were identified via searches of PubMed and IPA from inception to March 2011. Search terms included PSRs, PSRs certification, PSRs registration, PSRs education, and PSRs requirements. Articles describing the roles and responsibilities of PSRs, physician and public perception of PSRs, certification processes, and the future of PSRs' roles were included. An internet search was also performed to identify articles in the lay press related to this topic.
Findings
This paper shows that the certification for PSRs may become necessary, or even required, to help ensure that the prescribing patterns of physicians are not negatively affected due to false information coming from the PSRs. Therefore, ensuring that PSRs are well certified can lead to better health outcomes for patients. Although pharmaceutical companies do not require certification to gain employment as a sales representative, the certification provides a good knowledge base and insight into the industry.
Originality/value
The paper shows that appropriate training and certification of PSRs may be on the rise for this career path.
Details
Keywords
Javed Aslam, Aqeela Saleem and Yun Bae Kim
This study aims to proposed that blockchain helps the organization improve supply chain (SC) performance by improving integration, agility and security through real-time…
Abstract
Purpose
This study aims to proposed that blockchain helps the organization improve supply chain (SC) performance by improving integration, agility and security through real-time information sharing, end-to-end visibility, transparency, data management, immutability, irrevocable information and cyber-security platforms.
Design/methodology/approach
This study has made an initial effort toward proposing a framework that shows the problems and challenges for the O&G SC under its segments (upstream, midstream and downstream) and provides the interlink among blockchain properties for SCM problems. SC managers were selected for survey questionnaires from the Pakistan O&G industries.
Findings
This study analyzes the impact of blockchain-enabled SC on firm performance with an understanding of the SC robustness capabilities as a mediator. The result revealed that the SC manager believes that the blockchain-enabled SC has a positive and significant on firm performance and robustness capabilities.
Research limitations/implications
Blockchain technology is reflected as high-tech to support the firm process, responses and methods. The technology helps eliminate bottlenecks, avoid uncertainties and improve decision-making, leading to improved SC functions. This study guides managers about the potential problems of existing SC and how blockchain solves SC problems more effectively.
Originality/value
The oil and gas (O&G) sectors are neglected by researchers, and there are limited studies on O&G supply chain management (SCM). Additionally, no empirical evidence suggests implementing blockchain for O&G as a solution for potential problems. Furthermore, present the roadmap to other industries those having complex SC networks for the implication of blockchain to improve the SC performance.